Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial
- PMID: 28335893
- DOI: 10.1016/j.jcin.2016.12.028
Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial
Abstract
Objectives: This study sought to compare the outcomes of patients undergoing drug-eluting stent implantation according to lesion location within or outside the proximal left anterior descending (LAD) artery.
Background: Proximal LAD artery involvement is considered uniquely in revascularization guidelines. The impact of LAD lesion location on long-term outcomes after revascularization is poorly understood in context of current percutaneous coronary intervention and medical therapy.
Methods: Among 8,709 patients enrolled in PROTECT (Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial), a multicenter percutaneous coronary intervention trial, we compared the outcomes of 2,534 patients (29.1%) (3,871 lesions [31.5%]) with stents implanted in the proximal LAD to 6,172 patients (70.9%) (8,419 lesions [68.5%]) with stents implanted outside the proximal LAD.
Results: At the 4-year follow-up, death rates were the same (5.8% vs. 5.8%; p > 0.999), but more myocardial infarctions occurred in the proximal LAD group (6.2% vs. 4.9%; p = 0.015). The rate of clinically driven target vessel failure (TVF) (14.8% vs. 13.5%; p = 0.109), major adverse cardiac event(s) (MACE) (15.0% vs. 13.7%; hazard ratio: 1.1; 95% confidence interval: 0.97 to 1.31; p = 0.139), and stent thrombosis (2.1% vs. 2.0%; p = 0.800) were similar. Drug-eluting stent type had no interaction with MACE or TVF. In multivariate analysis, the proximal LAD was a predictor of myocardial infarction (p = 0.038) but not of TVF (p = 0.149) or MACE (p = 0.069).
Conclusions: In this study of contemporary percutaneous coronary intervention, proximal LAD location was associated with higher rates of myocardial infarction during the long-term follow-up, but there were no differences in stent thrombosis, death, TVF, or overall MACE. This finding may suggest that, in the drug-eluting stent era, proximal LAD no longer confers a different prognosis than other lesion sites. (Randomized Study Comparing Endeavor With Cypher Stents [PROTECT]; NCT00476957).
Keywords: angioplasty; coronary artery disease; decision making; guidelines; left anterior descending artery; stent.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Proximal Left Anterior Descending Coronary Artery PCI: Is it No Longer the Last Lesion Standing?JACC Cardiovasc Interv. 2017 Mar 27;10(6):557-559. doi: 10.1016/j.jcin.2017.01.024. JACC Cardiovasc Interv. 2017. PMID: 28335894 No abstract available.
Similar articles
-
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).JACC Cardiovasc Interv. 2013 Sep;6(9):914-22. doi: 10.1016/j.jcin.2013.05.005. JACC Cardiovasc Interv. 2013. PMID: 24050859
-
5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).JACC Cardiovasc Interv. 2013 Dec;6(12):1263-6. doi: 10.1016/j.jcin.2013.07.009. Epub 2013 Nov 13. JACC Cardiovasc Interv. 2013. PMID: 24239202 Clinical Trial.
-
Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.Catheter Cardiovasc Interv. 2013 May;81(6):E237-44. doi: 10.1002/ccd.24513. Epub 2012 Nov 14. Catheter Cardiovasc Interv. 2013. PMID: 22707383
-
Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.JACC Cardiovasc Interv. 2014 May;7(5):497-506. doi: 10.1016/j.jcin.2013.12.202. Epub 2014 Apr 16. JACC Cardiovasc Interv. 2014. PMID: 24746647 Review.
-
Cardiovascular outcomes associated with crush versus provisional stenting techniques for bifurcation lesions: a systematic review and meta-analysis.BMC Cardiovasc Disord. 2019 Apr 23;19(1):93. doi: 10.1186/s12872-019-1070-y. BMC Cardiovasc Disord. 2019. PMID: 31014237 Free PMC article.
Cited by
-
Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster Registry.J Am Heart Assoc. 2019 Dec 3;8(23):e013786. doi: 10.1161/JAHA.119.013786. Epub 2019 Nov 30. J Am Heart Assoc. 2019. PMID: 31787055 Free PMC article.
-
Association among β2-adrenergic receptor autoantibodies and proximal left anterior descending artery lesions in patients with initial ST-segment elevation myocardial infarction.Clin Cardiol. 2023 Nov;46(11):1371-1379. doi: 10.1002/clc.24129. Epub 2023 Aug 17. Clin Cardiol. 2023. PMID: 37587904 Free PMC article.
-
Long-term outcomes following ostial left anterior descending artery intervention with or without crossover to left-main.Am J Cardiovasc Dis. 2022 Apr 15;12(2):73-80. eCollection 2022. Am J Cardiovasc Dis. 2022. PMID: 35600287 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical